📰00Read later0Read MoreTeva's CNS Portfolio Is Growing, But Valuation Is StretchedSeeking Alpha·ALLKA Research·6 months ago#nJOSUJoO#source#chevron#alpha#teva#seeking+4 more🧰Tag tools✨Add tagTeva trades at the non-GAAP P/E ratio of 14.93x, which is 65.9% higher than Sanofi's. Find out why TEVA stock is a Sell.15s
